TNFRSF11B and breast cancer: We observed statistically significant higher mRNA expression levels (lower delta Ct values) for CCL2 (Fig. 4a), IL1B (Fig. 4b) and OPG (Fig. 4c) in the stage I breast cancer samples relative to normal samples.